PRIMEDTime April

​Join us for #Edinburgh's fourth 𝗣𝗥𝗜𝗠𝗘𝗗𝘁𝗶𝗺𝗲* with Dr Jack Scannell, CEO of Etheros Pharmaceuticals, a company developing small molecule enzyme mimetics for age-related and #neurodegenerative diseases.

​Jack is best known for his work to diagnose the causes of the progressive decline in R&D productivity in the #drug and #biotechnology industry. He also has experience in drug and biotech investment at UBS and at Sanford Bernstein where he ran the European Healthcare teams.

​What is it like to progress from a researcher to a CEO or enter the investment sector? Join us to hear Jack's journey, the future of the drug and #biotech industry, ask your burning questions, and meet fellow members of the PRIMED community in relaxed, friendly setting ☺️

​Whether you’re actively thinking about entrepreneurship or just curious about different career paths beyond the lab, we would love you to join us for this thoughtful and inspiring conversation! 🙂